Effects of the phosphodiesterase 4 inhibitors SB 207499 and AWD 12-281 on the inflammatory reaction in a model of allergic dermatitis (Q44050807)

29 November 2017

title

Effects of the phosphodiesterase 4 inhibitors SB 207499 and AWD 12-281 on the inflammatory reaction in a model of allergic dermatitis (English)

1 reference

29 November 2017

0 references

Wolfgang Bäumer

1

1 reference

29 November 2017

Gilbert Gorr

2

1 reference

29 November 2017

Joachim Hoppmann

3

1 reference

29 November 2017

Andreas M Ehinger

4

1 reference

29 November 2017

Britt Ehinger

5

1 reference

29 November 2017

Manfred Kietzmann

6

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

European Journal of Pharmacology

29 November 2017

published in

1 reference

29 November 2017

volume

446

1 reference

29 November 2017

issue

1-3

1 reference

29 November 2017

page(s)

195-200

1 reference

Increased leukocyte histamine release with elevated cyclic AMP-phosphodiesterase activity in atopic dermatitis

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

Cyclic nucleotide phosphodiesterase 4 subtypes are differentially expressed by primary keratinocytes and human epidermoid cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

Phosphodiesterase inhibition by Ro 20-1724 reduces hyper-IgE synthesis by atopic dermatitis cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

Murine mast cells exposed to mercuric chloride release granule-associated N-acetyl-beta-D-hexosaminidase and secrete IL-4 and TNF-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

Effects of the phosphodiesterase 4 inhibitor RPR 73401 in a model of immunological inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

Early molecular events in the induction phase of contact sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

Development and validation of an alternative dermal sensitization test: the mouse ear swelling test (MEST).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

Mast cell proteinases and cytokines in skin inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

Predictive value of airways hyperresponsiveness and circulating IgE for identifying types of responses to toluene diisocyanate inhalation challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

The role of keratinocyte cytokines in inflammation and immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

Long-term topical exposure to toluene diisocyanate in mice leads to antibody production and in vivo airway hyperresponsiveness three hours after intranasal challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

Inhibition of cytokine release by and cardiac effects of type IV phosphodiesterase inhibition in early, profound endotoxaemia in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901810-1

10.1016/S0014-2999(02)01810-1

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference